Colleen M Cebulla, MD, PhD
College of Medicine
Molecular Biology and Cancer Genetics
Cancer, Melanoma, Retinoblastoma, Retinal Detachment, Inflammation, Down Syndrome, Endometrial Cancer
Colleen Cebulla, MD, is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, where her research is focused on retinal detachments and uveal melanoma.Her research team has identified that over 10 percent of patients with uveal melanoma have a heritable cancer syndrome. With this understanding, the team seeks to identify the genes responsible for increased cancer in these families. The researchers have identified a new cancer syndrome caused by mutation in the BAP1 gene. Dr. Cebulla has co-authored dozens of articles, including over 16 between 2014 and the first six months of 2016, in well-respected journals such as Ocular Oncology and Pathology, Familial Cancer, Experimental Neurology and Genes, Chromosomes and Cancer.